Merck's Blockbuster Drug Wins Key New FDA Approval

One of the world's most successful drugs, Merck's (NYSE: MRK) Keytruda, stands to become even more prominent following an important new approval. The U.S. Food and Drug Administration (FDA) gave it the green light for the treatment of a particularly stubborn type of bladder cancer.